Brigham and Women's Hospital, Harvard Medical School Harvard University Cambridge, Massachusetts
Learning Objectives:
Describe the mechanisms of action of S1PR modulators and the implications for IBD management
Evaluate the most current clinical data associated with available and emerging S1PR modulators
Implement personalized treatment plans for patients with IBD by incorporating appropriate predictive biomarker analysis, improving patient communication, and addressing barriers to adherence
Presentations:
1:00 PM – 1:30 PM .
Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School